Cart
sales@molnova.com
Butyzamide
Butyzamide
Catalog No. M36057
Butyzamide is an effective and oral Mpl activator. It is a novel non-peptide-based molecule with antagonistic effects on thrombopoietin (TPO) receptors, which promotes proliferation of human Mpl (hMpl) expression and mouse pro B cell line Ba/F3.
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 347 | In Stock |
|
| 5MG | 266 | In Stock |
|
| 10MG | 392 | In Stock |
|
| 25MG | 605 | In Stock |
|
| 50MG | 890 | In Stock |
|
| 100MG | 1349 | In Stock |
|
| 200MG | 1814 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameButyzamide
-
Brief Description
-
Description
-
Storage
-
NoteResearch use only, not for human use.
-
Reference1. Nogami W, et al. The effect of a novel, small non-peptidyl molecule butyzamide on human thrombopoietin receptor and megakaryopoiesis. Haematologica. 2008 Oct;93(10):1495-504. ?
molnova catalog
related products
-
JAK-IN-10
JAK-IN-10 is a JAK inhibitor that can be used for the research of dry eye disorders.
-
Axltide
Axltide is based on the mouse Insulin receptor substrate 1 (amino acid 979-989).Peptide sequence (KKSRGDYMTMQIG) is based on the mouse Insulin receptor substrate 1 (amino acid 979-989).
-
Solcitinib
A potent, selective JAK1 inhibitor for the treatment of psoriasis, lupus, and ulcerative colitis.
